ID   FUBP2_HUMAN             Reviewed;         711 AA.
AC   Q92945; O00301; Q59EZ9; Q5U4P6; Q9UNT5; Q9UQH5;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 4.
DT   26-FEB-2020, entry version 191.
DE   RecName: Full=Far upstream element-binding protein 2;
DE            Short=FUSE-binding protein 2;
DE   AltName: Full=KH type-splicing regulatory protein;
DE            Short=KSRP;
DE   AltName: Full=p75;
GN   Name=KHSRP; Synonyms=FUBP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 72-85; 123-128; 267-281;
RP   283-291; 348-359; 474-488; 489-494; 621-627; 629-646 AND 647-653, AND
RP   FUNCTION.
RC   TISSUE=Neuroblastoma, and Retinoblastoma;
RX   PubMed=9136930; DOI=10.1101/gad.11.8.1023;
RA   Min H., Turck C.W., Nikolic J.M., Black D.L.;
RT   "A new regulatory protein, KSRP, mediates exon inclusion through an
RT   intronic splicing enhancer.";
RL   Genes Dev. 11:1023-1036(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-115 AND 573-711.
RX   PubMed=10087204; DOI=10.1006/geno.1998.5725;
RA   Ring H.Z., Vameghi-Meyers V., Nikolic J.M., Min H., Black D.L., Francke U.;
RT   "Mapping of the KHSRP gene to a region of conserved synteny on human
RT   chromosome 19p13.3 and mouse chromosome 17.";
RL   Genomics 56:350-352(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 60-711, AND FUNCTION.
RC   TISSUE=B-cell lymphoma, and Skeletal muscle;
RX   PubMed=8940189; DOI=10.1074/jbc.271.49.31679;
RA   Davis-Smyth T., Duncan R.C., Zheng T., Michelotti G., Levens D.;
RT   "The far upstream element-binding proteins comprise an ancient family of
RT   single-strand DNA-binding transactivators.";
RL   J. Biol. Chem. 271:31679-31687(1996).
RN   [6]
RP   PROTEIN SEQUENCE OF 151-162; 321-331 AND 385-394, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 183-566.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   FUNCTION, AND INTERACTION WITH PTBP1; PTBP2 AND HNRPH1.
RX   PubMed=11003644; DOI=10.1128/mcb.20.20.7463-7479.2000;
RA   Markovtsov V., Nikolic J.M., Goldman J.A., Turck C.W., Chou M.-Y.,
RA   Black D.L.;
RT   "Cooperative assembly of an hnRNP complex induced by a tissue-specific
RT   homolog of polypyrimidine tract binding protein.";
RL   Mol. Cell. Biol. 20:7463-7479(2000).
RN   [9]
RP   INTERACTION WITH PARN.
RX   PubMed=15175153; DOI=10.1016/j.molcel.2004.05.002;
RA   Gherzi R., Lee K.-Y., Briata P., Wegmueller D., Moroni C., Karin M.,
RA   Chen C.-Y.;
RT   "A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover
RT   by recruiting the degradation machinery.";
RL   Mol. Cell 14:571-583(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-100; SER-181 AND SER-274, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181 AND SER-480, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   INTERACTION WITH PQBP1.
RX   PubMed=21933836; DOI=10.1093/hmg/ddr430;
RA   Kunde S.A., Musante L., Grimme A., Fischer U., Mueller E., Wanker E.E.,
RA   Kalscheuer V.M.;
RT   "The X-chromosome-linked intellectual disability protein PQBP1 is a
RT   component of neuronal RNA granules and regulates the appearance of stress
RT   granules.";
RL   Hum. Mol. Genet. 20:4916-4931(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181; SER-274 AND SER-480, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99; SER-125; SER-129;
RP   SER-131; SER-181; SER-184; SER-193; SER-274 AND SER-480, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [26]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-411; ARG-413; ARG-415 AND
RP   ARG-442, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [27]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-121, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [29]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-121, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [30]
RP   STRUCTURE BY NMR OF 218-418 AND 423-525.
RX   PubMed=17437720; DOI=10.1016/j.str.2007.03.006;
RA   Garcia-Mayoral M.F., Hollingworth D., Masino L., Diaz-Moreno I., Kelly G.,
RA   Gherzi R., Chou C.F., Chen C.Y., Ramos A.;
RT   "The structure of the C-terminal KH domains of KSRP reveals a noncanonical
RT   motif important for mRNA degradation.";
RL   Structure 15:485-498(2007).
RN   [31]
RP   STRUCTURE BY NMR OF 130-218 AND 221-305, PHOSPHORYLATION AT SER-193, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=19198587; DOI=10.1038/nsmb.1558;
RA   Diaz-Moreno I., Hollingworth D., Frenkiel T.A., Kelly G., Martin S.,
RA   Howell S., Garcia-Mayoral M., Gherzi R., Briata P., Ramos A.;
RT   "Phosphorylation-mediated unfolding of a KH domain regulates KSRP
RT   localization via 14-3-3 binding.";
RL   Nat. Struct. Mol. Biol. 16:238-246(2009).
CC   -!- FUNCTION: Binds to the dendritic targeting element and may play a role
CC       in mRNA trafficking (By similarity). Part of a ternary complex that
CC       binds to the downstream control sequence (DCS) of the pre-mRNA.
CC       Mediates exon inclusion in transcripts that are subject to tissue-
CC       specific alternative splicing. May interact with single-stranded DNA
CC       from the far-upstream element (FUSE). May activate gene expression.
CC       Also involved in degradation of inherently unstable mRNAs that contain
CC       AU-rich elements (AREs) in their 3'-UTR, possibly by recruiting
CC       degradation machinery to ARE-containing mRNAs. {ECO:0000250,
CC       ECO:0000269|PubMed:11003644, ECO:0000269|PubMed:8940189,
CC       ECO:0000269|PubMed:9136930}.
CC   -!- SUBUNIT: Part of a ternary complex containing FUBP2, PTBP1, PTBP2 and
CC       HNRPH1 (PubMed:11003644). Interacts with PARN (PubMed:15175153).
CC       Interacts with PQBP1 (PubMed:21933836). {ECO:0000269|PubMed:11003644,
CC       ECO:0000269|PubMed:15175153, ECO:0000269|PubMed:21933836}.
CC   -!- INTERACTION:
CC       Q9UPY3-1:DICER1; NbExp=3; IntAct=EBI-1049099, EBI-15569571;
CC       P63101:Ywhaz (xeno); NbExp=2; IntAct=EBI-1049099, EBI-354751;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19198587}. Cytoplasm
CC       {ECO:0000269|PubMed:19198587}. Note=A small proportion is also found in
CC       the cytoplasm of neuronal cell bodies and dendrites. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Detected in neural and non-neural cell lines.
CC   -!- DOMAIN: KH domains KH 3 and KH 4 behave as independent binding modules
CC       and can interact with different regions of the AU-rich RNA targets of
CC       degradation.
CC   -!- PTM: Phosphorylation at Ser-193 leads to the unfolding of the unstable
CC       KH domain 1, creating a site for 14-3-3 YWHAZ binding, which promotes
CC       nuclear localization and impairs the RNA degradation function.
CC       {ECO:0000269|PubMed:19198587}.
CC   -!- SIMILARITY: Belongs to the KHSRP family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC50892.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAH85004.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U94832; AAB53222.1; -; mRNA.
DR   EMBL; AC011491; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011539; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC085004; AAH85004.1; ALT_SEQ; mRNA.
DR   EMBL; AF093747; AAD29861.1; -; Genomic_DNA.
DR   EMBL; AF093745; AAD29861.1; JOINED; Genomic_DNA.
DR   EMBL; AF093748; AAD29862.1; -; Genomic_DNA.
DR   EMBL; U69126; AAC50892.1; ALT_FRAME; mRNA.
DR   EMBL; AB209662; BAD92899.1; -; mRNA.
DR   CCDS; CCDS45936.1; -.
DR   RefSeq; NP_003676.2; NM_003685.2.
DR   PDB; 2HH2; NMR; -; A=424-525.
DR   PDB; 2HH3; NMR; -; A=318-418.
DR   PDB; 2JVZ; NMR; -; A=233-396.
DR   PDB; 2OPU; NMR; -; A=130-218.
DR   PDB; 2OPV; NMR; -; A=221-305.
DR   PDB; 4B8T; NMR; -; A=317-418.
DR   PDBsum; 2HH2; -.
DR   PDBsum; 2HH3; -.
DR   PDBsum; 2JVZ; -.
DR   PDBsum; 2OPU; -.
DR   PDBsum; 2OPV; -.
DR   PDBsum; 4B8T; -.
DR   SMR; Q92945; -.
DR   BioGrid; 114139; 137.
DR   CORUM; Q92945; -.
DR   DIP; DIP-48484N; -.
DR   ELM; Q92945; -.
DR   IntAct; Q92945; 50.
DR   MINT; Q92945; -.
DR   STRING; 9606.ENSP00000381216; -.
DR   ChEMBL; CHEMBL1795105; -.
DR   DrugBank; DB11638; Artenimol.
DR   DrugBank; DB02709; Resveratrol.
DR   iPTMnet; Q92945; -.
DR   PhosphoSitePlus; Q92945; -.
DR   SwissPalm; Q92945; -.
DR   BioMuta; KHSRP; -.
DR   DMDM; 313104306; -.
DR   REPRODUCTION-2DPAGE; Q92945; -.
DR   EPD; Q92945; -.
DR   jPOST; Q92945; -.
DR   MassIVE; Q92945; -.
DR   MaxQB; Q92945; -.
DR   PaxDb; Q92945; -.
DR   PeptideAtlas; Q92945; -.
DR   PRIDE; Q92945; -.
DR   ProteomicsDB; 75616; -.
DR   Ensembl; ENST00000398148; ENSP00000381216; ENSG00000088247.
DR   GeneID; 8570; -.
DR   KEGG; hsa:8570; -.
DR   UCSC; uc002mer.5; human.
DR   CTD; 8570; -.
DR   DisGeNET; 8570; -.
DR   GeneCards; KHSRP; -.
DR   HGNC; HGNC:6316; KHSRP.
DR   HPA; HPA034739; -.
DR   HPA; HPA056518; -.
DR   MIM; 603445; gene.
DR   neXtProt; NX_Q92945; -.
DR   OpenTargets; ENSG00000088247; -.
DR   PharmGKB; PA30097; -.
DR   eggNOG; KOG1676; Eukaryota.
DR   eggNOG; ENOG410XZYE; LUCA.
DR   GeneTree; ENSGT00940000156051; -.
DR   HOGENOM; CLU_014285_1_0_1; -.
DR   InParanoid; Q92945; -.
DR   KO; K13210; -.
DR   OrthoDB; 590738at2759; -.
DR   PhylomeDB; Q92945; -.
DR   TreeFam; TF313654; -.
DR   Reactome; R-HSA-380994; ATF4 activates genes in response to endoplasmic reticulum stress.
DR   Reactome; R-HSA-450604; KSRP (KHSRP) binds and destabilizes mRNA.
DR   SIGNOR; Q92945; -.
DR   ChiTaRS; KHSRP; human.
DR   EvolutionaryTrace; Q92945; -.
DR   GeneWiki; KHSRP; -.
DR   GenomeRNAi; 8570; -.
DR   Pharos; Q92945; Tbio.
DR   PRO; PR:Q92945; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q92945; protein.
DR   Bgee; ENSG00000088247; Expressed in testis and 235 other tissues.
DR   ExpressionAtlas; Q92945; baseline and differential.
DR   Genevisible; Q92945; HS.
DR   GO; GO:0010494; C:cytoplasmic stress granule; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0035925; F:mRNA 3'-UTR AU-rich region binding; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0061158; P:3'-UTR-mediated mRNA destabilization; IDA:UniProtKB.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; IMP:UniProtKB.
DR   GO; GO:0010586; P:miRNA metabolic process; IMP:UniProtKB.
DR   GO; GO:0006402; P:mRNA catabolic process; IEA:Ensembl.
DR   GO; GO:0006397; P:mRNA processing; TAS:ProtInc.
DR   GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW.
DR   GO; GO:0010989; P:negative regulation of low-density lipoprotein particle clearance; IGI:BHF-UCL.
DR   GO; GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0061014; P:positive regulation of mRNA catabolic process; IDA:UniProtKB.
DR   GO; GO:2000628; P:regulation of miRNA metabolic process; IEA:Ensembl.
DR   GO; GO:0043488; P:regulation of mRNA stability; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0008380; P:RNA splicing; TAS:UniProtKB.
DR   GO; GO:0000375; P:RNA splicing, via transesterification reactions; TAS:UniProtKB.
DR   DisProt; DP01590; -.
DR   Gene3D; 3.30.1370.10; -; 4.
DR   InterPro; IPR015096; FUBP_C.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   Pfam; PF09005; DUF1897; 2.
DR   Pfam; PF00013; KH_1; 4.
DR   SMART; SM00322; KH; 4.
DR   SUPFAM; SSF54791; SSF54791; 4.
DR   PROSITE; PS50084; KH_TYPE_1; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing;
KW   DNA-binding; Isopeptide bond; Methylation; mRNA processing; mRNA splicing;
KW   mRNA transport; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   RNA-binding; Transcription; Transcription regulation; Transport;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378"
FT   CHAIN           2..711
FT                   /note="Far upstream element-binding protein 2"
FT                   /id="PRO_0000050137"
FT   DOMAIN          144..208
FT                   /note="KH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          233..299
FT                   /note="KH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          322..386
FT                   /note="KH 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          424..491
FT                   /note="KH 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   REPEAT          571..582
FT                   /note="1"
FT   REPEAT          617..628
FT                   /note="2"
FT   REPEAT          643..654
FT                   /note="3"
FT   REPEAT          673..684
FT                   /note="4"
FT   REGION          571..684
FT                   /note="4 X 12 AA imperfect repeats"
FT   COMPBIAS        7..67
FT                   /note="Gly/Pro-rich"
FT   COMPBIAS        68..496
FT                   /note="Gly-rich"
FT   COMPBIAS        498..612
FT                   /note="Ala/Gly/Pro-rich"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378"
FT   MOD_RES         40
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3U0V1"
FT   MOD_RES         87
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3U0V1"
FT   MOD_RES         99
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         100
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         125
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         129
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         131
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         181
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         184
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         193
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000269|PubMed:19198587"
FT   MOD_RES         274
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         411
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         413
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         415
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         442
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         480
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   CROSSLNK        121
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   CROSSLNK        121
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CONFLICT        46
FT                   /note="G -> C (in Ref. 1; AAB53222 and 4; AAD29861)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        96
FT                   /note="V -> G (in Ref. 5; AAC50892)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        406..407
FT                   /note="MP -> I (in Ref. 5; AAC50892)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        422
FT                   /note="Missing (in Ref. 5; AAC50892)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        487..488
FT                   /note="AK -> CR (in Ref. 5; AAC50892)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        694..696
FT                   /note="GPG -> VP (in Ref. 5; AAC50892)"
FT                   /evidence="ECO:0000305"
FT   STRAND          132..134
FT                   /evidence="ECO:0000244|PDB:2OPU"
FT   HELIX           141..144
FT                   /evidence="ECO:0000244|PDB:2OPU"
FT   STRAND          146..151
FT                   /evidence="ECO:0000244|PDB:2OPU"
FT   HELIX           153..159
FT                   /evidence="ECO:0000244|PDB:2OPU"
FT   TURN            161..163
FT                   /evidence="ECO:0000244|PDB:2OPU"
FT   HELIX           165..174
FT                   /evidence="ECO:0000244|PDB:2OPU"
FT   STRAND          179..183
FT                   /evidence="ECO:0000244|PDB:2OPU"
FT   STRAND          188..194
FT                   /evidence="ECO:0000244|PDB:2OPU"
FT   HELIX           198..216
FT                   /evidence="ECO:0000244|PDB:2OPU"
FT   STRAND          234..240
FT                   /evidence="ECO:0000244|PDB:2JVZ"
FT   TURN            242..244
FT                   /evidence="ECO:0000244|PDB:2OPV"
FT   TURN            245..249
FT                   /evidence="ECO:0000244|PDB:2JVZ"
FT   TURN            251..253
FT                   /evidence="ECO:0000244|PDB:2JVZ"
FT   HELIX           254..261
FT                   /evidence="ECO:0000244|PDB:2JVZ"
FT   STRAND          265..269
FT                   /evidence="ECO:0000244|PDB:2JVZ"
FT   STRAND          271..273
FT                   /evidence="ECO:0000244|PDB:2OPV"
FT   STRAND          275..279
FT                   /evidence="ECO:0000244|PDB:2JVZ"
FT   STRAND          281..287
FT                   /evidence="ECO:0000244|PDB:2JVZ"
FT   HELIX           289..302
FT                   /evidence="ECO:0000244|PDB:2JVZ"
FT   STRAND          306..308
FT                   /evidence="ECO:0000244|PDB:2JVZ"
FT   TURN            317..319
FT                   /evidence="ECO:0000244|PDB:4B8T"
FT   STRAND          325..330
FT                   /evidence="ECO:0000244|PDB:2HH3"
FT   TURN            331..333
FT                   /evidence="ECO:0000244|PDB:2HH3"
FT   HELIX           334..338
FT                   /evidence="ECO:0000244|PDB:2HH3"
FT   STRAND          340..342
FT                   /evidence="ECO:0000244|PDB:2JVZ"
FT   HELIX           343..352
FT                   /evidence="ECO:0000244|PDB:2HH3"
FT   STRAND          355..358
FT                   /evidence="ECO:0000244|PDB:2HH3"
FT   STRAND          363..375
FT                   /evidence="ECO:0000244|PDB:2HH3"
FT   HELIX           376..393
FT                   /evidence="ECO:0000244|PDB:2HH3"
FT   STRAND          400..405
FT                   /evidence="ECO:0000244|PDB:4B8T"
FT   TURN            413..415
FT                   /evidence="ECO:0000244|PDB:4B8T"
FT   STRAND          427..432
FT                   /evidence="ECO:0000244|PDB:2HH2"
FT   HELIX           433..435
FT                   /evidence="ECO:0000244|PDB:2HH2"
FT   TURN            436..438
FT                   /evidence="ECO:0000244|PDB:2HH2"
FT   TURN            441..444
FT                   /evidence="ECO:0000244|PDB:2HH2"
FT   HELIX           446..453
FT                   /evidence="ECO:0000244|PDB:2HH2"
FT   STRAND          454..460
FT                   /evidence="ECO:0000244|PDB:2HH2"
FT   STRAND          472..479
FT                   /evidence="ECO:0000244|PDB:2HH2"
FT   HELIX           481..494
FT                   /evidence="ECO:0000244|PDB:2HH2"
SQ   SEQUENCE   711 AA;  73115 MW;  AB0B7C0B5B938114 CRC64;
     MSDYSTGGPP PGPPPPAGGG GGAGGAGGGP PPGPPGAGDR GGGGPGGGGP GGGSAGGPSQ
     PPGGGGPGIR KDAFADAVQR ARQIAAKIGG DAATTVNNST PDFGFGGQKR QLEDGDQPES
     KKLASQGDSI SSQLGPIHPP PRTSMTEEYR VPDGMVGLII GRGGEQINKI QQDSGCKVQI
     SPDSGGLPER SVSLTGAPES VQKAKMMLDD IVSRGRGGPP GQFHDNANGG QNGTVQEIMI
     PAGKAGLVIG KGGETIKQLQ ERAGVKMILI QDGSQNTNVD KPLRIIGDPY KVQQACEMVM
     DILRERDQGG FGDRNEYGSR IGGGIDVPVP RHSVGVVIGR SGEMIKKIQN DAGVRIQFKQ
     DDGTGPEKIA HIMGPPDRCE HAARIINDLL QSLRSGPPGP PGGPGMPPGG RGRGRGQGNW
     GPPGGEMTFS IPTHKCGLVI GRGGENVKAI NQQTGAFVEI SRQLPPNGDP NFKLFIIRGS
     PQQIDHAKQL IEEKIEGPLC PVGPGPGGPG PAGPMGPFNP GPFNQGPPGA PPHAGGPPPH
     QYPPQGWGNT YPQWQPPAPH DPSKAAAAAA DPNAAWAAYY SHYYQQPPGP VPGPAPAPAA
     PPAQGEPPQP PPTGQSDYTK AWEEYYKKIG QQPQQPGAPP QQDYTKAWEE YYKKQAQVAT
     GGGPGAPPGS QPDYSAAWAE YYRQQAAYYG QTPGPGGPQP PPTQQGQQQA Q
//
